CASI Pharmaceuticals, Inc. Investment Agreements
6 Contracts & Agreements
- Equity Transfer Agreement between CASI Biopharmaceuticals (Wuxi) Co., Ltd. and Shenzhen Jiadao Gongcheng Equity Investment Fund (Limited Partnership) dated September 22, 2022 (Filed With SEC on November 14, 2022)
- Investment Agreement by and between Juventas Cell Therapy Ltd and CASI Biopharmaceuticals (WUXI) Co., Ltd. effective as of September 22, 2020 (Filed With SEC on November 9, 2020)
- Investment Agreement in respect of Juventas Cell Therapy Ltd. executed June 15, 2019 (Filed With SEC on August 9, 2019)
- Shareholders Agreement, dated November 16, 2018, between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise (Limited Partnership) (Filed With SEC on March 29, 2019)
- INVESTMENT AGREEMENT (Filed With SEC on September 19, 2014)
- INVESTMENT AGREEMENT (Filed With SEC on September 19, 2014)
